High Risk Characteristics for Recurrent Cardiovascular Events among Patients with Obstructive Sleep Apnoea in the SAVE Study
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Obstructive sleep apnoea (OSA) is a common comorbidity in patients with cardiovascular (CV) disease. We aimed to identify specific OSA clinical phenotypes relating to risks of serious CV events and response to continuous positive airway pressure (CPAP) treatment. METHODS: Post-hoc analyses of the Sleep Apnea Cardiovascular Endpoints (SAVE) study in participants with moderate-to-severe OSA and coronary artery disease (CAD) and/or cerebrovascular disease (CeVD) randomised to CPAP plus usual care or usual care alone. Latent class analysis (LCA) was used to identify OSA clinical phenotypes among 2649 (out of 2687 total) patients with complete data on 19 patient-centered variables, supported by Bayesian information criteria and clinical interpretability. Cox regression models were used to evaluate risks of composite cardiac and stroke outcome events in phenotype groups. Preferential response to CPAP treatment was evaluated using interaction terms as well as the Chi-square test. FINDINGS: LCA identified four OSA clinical phenotypes: CAD alone and with diabetes mellitus (CAD + DM), and CeVD alone and with DM (CeVD + DM), in 39%, 15%, 37% and 9% of participants, respectively. The rates of composite CV events were the highest in CAD + DM phenotype (HR 2.08, 95% CI 1.57-2.76) and for stroke were highest in CeVD + DM phenotype (HR 6.84, 95% CI 3.77-12.42). Adherence to CPAP treatment (nil or < 4 h vs ≥ 4 h in the first two years of the study) was shown to influence the risk of composite CV outcome in the phenotypes (P-interaction = 0.04); CPAP adherent patients of the CeVD + DM phenotype had the lowest risk of CV outcome (P = 0.02). INTERPRETATION: High risk clinical phenotypes were identified in relation to CV events and response to CPAP treatment, which may allow improved targeting of therapies in OSA patients. FUNDING: The National Health and Medical Research Council (NHMRC) of Australia, Fisher & Paykel Healthcare, and ResMed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marin, J. M., Carrizo, S. J., Vicente, E., & Agusti, A. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71141-7 · Cited by 4,678
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., & Mohsenin, V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043104 · Cited by 3,004 · cited 1×
“Interestingly, more patients in the CeVD groups had severe OSA compared to CAD groups, which is consistent with studies showing a dose-dependent relationship of OSA severity and risk of stroke [21,22], but not CAD [22].”
ResultSleep-disordered Breathing and Cardiovascular Disease
SHAHAR, E., WHITNEY, C. W., REDLINE, S., LEE, E. T., NEWMAN, A. B., JAVIER NIETO, F., O'CONNOR, G. T., BOLAND, L. L., SCHWARTZ, J. E., & SAMET, J. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2001008 · Cited by 2,901 · cited 1×
“Interestingly, more patients in the CeVD groups had severe OSA compared to CAD groups, which is consistent with studies showing a dose-dependent relationship of OSA severity and risk of stroke [21,22], but not CAD [22].”
ResultCPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
McEvoy, R. D., Antic, N. A., Heeley, E., Luo, Y., Ou, Q., Zhang, X., Mediano, O., Chen, R., Drager, L. F., Liu, Z., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606599 · Cited by 2,101
Self-citationGoldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189375 · Cited by 1,450
Barbé, F., Durán-Cantolla, J., Sánchez-de-la-Torre, M., Martínez-Alonso, M., Carmona, C., Barceló, A., Chiner, E., Masa, J. F., Gonzalez, M., Marín, J. M., et al. (2012) · JAMA · doi:10.1001/jama.2012.4366 · Cited by 792 · cited 1×
“Although observational studies and small randomised trials have suggested benefits of CPAP on CV risk [6,7,24,25], the SAVE trial showed no effects of this treatment on either the main composite or individual components of the primary CV outcome in a high risk OSA population.”
BackgroundSelf-citationPeker, Y., Glantz, H., Eulenburg, C., Wegscheider, K., Herlitz, J., & Thunström, E. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201601-0088oc · Cited by 756 · cited 1×
“Although observational studies and small randomised trials have suggested benefits of CPAP on CV risk [6,7,24,25], the SAVE trial showed no effects of this treatment on either the main composite or individual components of the primary CV outcome in a high risk OSA population.”
BackgroundThe different clinical faces of obstructive sleep apnoea: a cluster analysis
Ye, L., Pien, G. W., Ratcliffe, S. J., Björnsdottir, E., Arnardottir, E. S., Pack, A. I., Benediktsdottir, B., & Gislason, T. (2014) · European Respiratory Journal · doi:10.1183/09031936.00032314 · Cited by 474
Yu, J., Zhou, Z., McEvoy, R. D., Anderson, C. S., Rodgers, A., Perkovic, V., & Neal, B. (2017) · JAMA · doi:10.1001/jama.2017.7967 · Cited by 371
Self-citationObstructive Sleep Apnea and Cardiovascular Events After Percutaneous Coronary Intervention
Lee, C.-H., Sethi, R., Li, R., Ho, H.-H., Hein, T., Jim, M.-H., Loo, G., Koo, C.-Y., Gao, X.-F., Chandra, S., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019392 · Cited by 232 · cited 1×
“Obstructive sleep apnoea (OSA) is a common disorder characterised by snoring and repetitive obstruction of the airways during sleep which affects up to two thirds of patients with cardiovascular (CV) risk factors [1,2].”
BackgroundMartínez-Cerón, E., Barquiel, B., Bezos, A.-M., Casitas, R., Galera, R., García-Benito, C., Hernanz, A., Alonso-Fernández, A., & Garcia-Rio, F. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-1942oc · Cited by 214
Campos-Rodriguez, F., Martinez-Garcia, M. A., Reyes-Nuñez, N., Caballero-Martinez, I., Catalan-Serra, P., & Almeida-Gonzalez, C. V. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201311-2012oc · Cited by 183 · cited 1×
“Although observational studies and small randomised trials have suggested benefits of CPAP on CV risk [6,7,24,25], the SAVE trial showed no effects of this treatment on either the main composite or individual components of the primary CV outcome in a high risk OSA population.”
BackgroundClinical Phenotypes and Comorbidity in European Sleep Apnoea Patients
Saaresranta, T., Hedner, J., Bonsignore, M. R., Riha, R. L., McNicholas, W. T., Penzel, T., Anttalainen, U., Kvamme, J. A., Pretl, M., Sliwinski, P., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163439 · Cited by 154
Vavougios, G. D., Natsios, G., Pastaka, C., Zarogiannis, S. G., & Gourgoulianis, K. I. (2016) · Journal of Sleep Research · doi:10.1111/jsr.12344 · Cited by 104 · cited 1×
“Prior attempts to phenotype OSA patients have primarily been based on symptoms and polysomnographic features in small, carefully selected series [10,12,14,28,29].”
Method
Cited by
Global burden of sleep‐disordered breathing and its implications
Lyons, M. M., Bhatt, N. Y., Pack, A. I., & Magalang, U. J. (2020) · Respirology · doi:10.1111/resp.13838 · Cited by 422
Obstructive sleep apnoea heterogeneity and cardiovascular disease
Redline, S., Azarbarzin, A., & Peker, Y. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00846-6 · Cited by 325
Zinchuk, A., & Yaggi, H. K. (2020) · Chest · doi:10.1016/j.chest.2019.09.002 · Cited by 289
Obstructive sleep apnea and comorbidities: a dangerous liaison
Bonsignore, M. R., Baiamonte, P., Mazzuca, E., Castrogiovanni, A., & Marrone, O. (2019) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-019-0172-9 · Cited by 258
Labarca, G., Dreyse, J., Salas, C., Letelier, F., & Jorquera, J. (2021) · Chest · doi:10.1016/j.chest.2021.06.047 · Cited by 75
Metadata
- Authors
- Quan, W., Zheng, D., Douglas McEvoy, R., Barbe, F., Chen, R., Liu, Z., Loffler, K., Lorenzi-Filho, G., Luo, Y., Mukherjee, S., Tripathi, M., Woodman, R., Li, Q., Wang, X., Arima, H., Xiao, Y., Zhang, X., & Anderson, C. S.
- Venue
- EClinicalMedicine
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 2-3
- Pages
- 59-65
- ISSN
- 2589-5370 (ISSN-L)
- OpenAlex
- W2891015082
- Cited by
- 54
- References
- 14
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.